Science News & Science Current Events
 
Email a Friend Send to a friend
Printer Friendly Print Angina drug potentially useful against heart rhythm disorders

Angina drug potentially useful against heart rhythm disorders

April 01, 2008

Rare genetic syndromes provide insights into post-heart attack electrophysiology

A recently approved angina drug may also represent a powerful new treatment for a rare hereditary syndrome that places teens at risk for sudden cardiac death, according to research presented to today at the 57th Annual Scientific Sessions of the American College of Cardiology (ACC) in Chicago.




Cardiac arrhythmias are electrical malfunctions that throw the heart out of rhythm, causing many of the 330,000 sudden cardiac deaths each year in the United States. Most fatal arrhythmias occur in aging patients when scar tissue left by a heart attack interferes with the heart's electrical system. As many as 1,000 deaths each year, however, are caused by Long QT Syndrome (LQTS), which occurs mostly in teens with otherwise healthy hearts. While rare, LQTS is yielding insights into the much more common post-heart attack arrhythmias, researchers said.

The QT interval is part of the heart's electrical signature as recorded by an electrocardiogram (ECG). The QT represents the time it takes for the heart's lower chambers to "reset" electrically after each heartbeat. QTc is QT corrected for heart rate, a more accurate measure. In LQTS patients, QTc reset time is prolonged, which makes the heart more susceptible to fatal arrhythmias. The condition may go unnoticed until sports, strong emotions or even loud noises knock the heart out of rhythm, causing loss of pulse and consciousness (syncope). Sudden death will then occur if the heart is not restarted with a defibrillator. Given the current state of awareness, some families have lost a second child before realizing all the children have the syndrome.

In the current, pilot study, researchers found that a drug, ranolazine (brand name Ranexa, CV Therapeutics) shortens the QT interval by about 5 percent; just enough to reduce symptoms and risks associated with one form of LQTS (LQT3-deltaKPQ). It is one of three forms of the disease that together make up 90 percent of LQTS cases. Past studies have shown that patients with angina, severe chest pain caused by inadequate blood flow to the heart, are also more likely to experience arrhythmias. Researchers got a clue that ranolazine, approved in January 2006, might influence QTc during its angina clinical trials, where it was found to have electrophysiological side effects.

"Past studies have shown that people with angina are also at risk for rhythm disorders," said Arthur Moss, M.D., professor of Medicine in the Department of Medicine at the University of Rochester Medical Center and lead author on the ranolazine abstract. "Our study found that we may be able to treat two conditions for the price of one with this drug. Specifically, Ranolazine shortens the QTc interval and improves myocardial relaxation in patients with the LQT3 mutation."

In a carefully controlled setting, and with informed consent, researchers gave five patients with the LQT3 mutation an 8-hour intravenous infusion of ranolazine, with ECG and ECHO evaluation before, during, and after treatment. Over the infusion period, the mean reduction in QTc from baseline was 26 +/- 3ms (p<0.0001). This represents about a five percent reduction in the QTc duration, researchers said.

In addition, researchers observed a significant 13 percent shortening in left ventricular isovolumic relaxation time and a significant 25 percent increase in mitral E-wave velocity during the infusion. Both are measures of how well an important chamber of the heart, the left ventricle, relaxes after each heartbeat, enabling it to fill with blood before the next contraction. Past studies have shown that the ability of the ventricle to relax is lessened, not just in Long QT, but also in more common post-heart attack arrhythmias and in conditions including hypertension, coronary artery disease and diabetes. Researchers said that ranolazine was the first treatment to bring about improved ventricular relaxation. No adverse effects of ranolazine were observed.

Cell Circuitry

Atoms and molecules have an undefined property called charge that explains how they behave. Like charges repel each other and opposites attract. Pulling apart two particles that are attracted to each other (separation of charge) creates potential energy that can be put to work. Cells have harnessed charge and potential energy to drive life processes by pumping charged particles into or out of cells.

The buildup of charged particles on one side of a cell membrane (membrane potential) means those particles will rush back if given the chance. That chance comes, under carefully regulated circumstances, with the opening of channel proteins that enable charged particle flow. The flow serves as a switch, kicking on cell functions. In heart muscle cells, for instance, signaling mechanisms coordinate the flow of sodium, potassium and calcium ions to create the potential energy needed for the cells to contract. By contracting in unison, many heart muscle cells bring about the heartbeat. After each heart muscle cell contracts in response to a rush of charged particles, those particles must be pumped back across the membrane to re-create separation of charge (repolarize it), and get it ready for the next contraction, all within milliseconds.

Changes to ion channels, whether caused by disease, aging or LQTS, can cause channel proteins to leak charged particles, which alters the timing of the heartbeat. Ranolazine was found to block late sodium ion current in those patients with mutations of the LQT3 type examined in the current study. The net effect was a significant shortening/improvement of repolarization as measured by QTc duration.



University of Rochester Medical Center



Related Heart Rhythm Current Events and Heart Rhythm News Articles Heart Rhythm Current Events and Heart Rhythm News RSS Heart Rhythm Current Events and Heart Rhythm News RSS
Study provides insight on a common heart rhythm disorder
University of Iowa researchers and colleagues in France have identified a gene variant that causes a potentially fatal human heart rhythm disorder called sinus node disease.

Novel Imaging Approach May Assist in Predicting Success of Treatment For Atrial Fibrillation
University of Utah researchers have developed a magnetic resonance imaging (MRI)-based method for detecting and quantifying injury to the wall of the heart's left atrium in patients who have undergone a procedure to treat atrial fibrillation.

Blood thinning drug linked to increased bleeding in brain
A new study shows that people who take the commonly used blood thinning drug warfarin may have larger amounts of bleeding in the brain and increased risk of death if they suffer a hemorrhagic stroke.

Mayo Clinic Chest Surgeons Propose Measures for Indicating Quality of Lung Surgery
Even though 30,000 patients in the United States undergo lung surgery each year, no standard criteria exist to measure the quality of their care. In the current issue of The Annals of Thoracic Surgery, Mayo Clinic surgeons have proposed a system of lung surgery quality indicators for surgeons and the public as a method to demonstrate best practices for obtaining positive patient outcomes.

Air pollution damages more than lungs: Heart and blood vessels suffer too
As athletes from around the world compete in the Beijing Olympics, many are on alert for respiratory problems caused by air pollution. They should also be concerned about its toxic effects on the heart and cardiovascular system, mounting research shows.

First human use of new device to make arrhythmia treatment safer
On June 16, 2008, Barbara Ganschow of Palatine, IL, became the first person in the world to be successfully treated with a new device designed to make it safer and easier for heart specialists to create a hole in the cardiac atrial septum.

Mayo Clinic spearheads research to discover unsuspected gene for atrial fibrillation
Mayo Clinic researchers have found a gene mutation linked to one family's hereditary form of atrial fibrillation. Researchers hope this discovery will lead to better understanding of the disease and, eventually, better ways to predict, prevent and treat the heart rhythm problem.

New system devised to guide doctors treating patients with symptomatic myocardial bridging
What type of intervention, if any, should cardiologists offer their patients who have a heart abnormality called myocardial bridging and symptoms of heart problems?

The Montreal Heart Institute presents findings on congestive heart failure and atrial fibrillation
The results of a major international clinical trial coordinated by the Montreal Heart Institute were reported today in the New England Journal of Medicine.

Computers as safe as medical experts for prescribing blood thinning drugs
The largest ever study into the administration of blood thinning drugs, principally Warfarin, has concluded that dosages calculated by computer are at least as safe and reliable as those provided by expert medical professionals.
More Heart Rhythm Current Events and Heart Rhythm News Articles


Energizing Heart Rhythm Meditation
by Susanna Bair

Emotion and Energy: You'll discover an inexhaustible source of power within; you will harness the power of your heart's passion to confront what you need to face, stop self-defeating actions and do what you don't think you can do. Happiness: In every heart there is a source of profound happiness, a happiness that needs no external reason. Your Greatness: As you energize your heart you'll find...



You and Your Arrhythmia: A Guide to Heart Rhythm Problems for Patients & Their Families
by John A. Kastor

This book includes cases with simple explanations to provide patients and their families with a better understanding of heart rhythm disorders, diagnosis, treatment, and long-term...



Living from the Heart: Heart Rhythm Meditation for Energy, Clarity, Peace, Joy, and Inner Power
by Puran Khan Bair

Living from the Heart introduces an innovative, Sufi-based meditation method for improving daily life. Through becoming mindful of the heartbeat readers will be able to create a deep state of stillness and alertness, improve physical health, enhance intuition, and concentrate personal power. Bair illustrates the effectiveness of his program with stories of clients he has helped and with ancient...



Heart Diseases and Disorders Sourcebook: Basic Consumer Health Information About Heart Attacks, Angina, Rhythm Disorders, Heart Failure, Valve Disease, ... and More (Health Reference Series)

Heart disease has been the leading cause of death in the United States since 1910. According to estimates made by the Centers for Disease Control and Prevention (CDC), approximately 57 million Americans currently live with some form of cardiovascular disease. The new edition of Heart Diseases & Disorders Sourcebook supplies the tools people need to maintain healthy hearts. It provides basic...



Listening to the Rhythm of the Heart
by Susan Spalding

How real are our lives? How connected are they to our hearts? The rhythm of the inner heart, sometimes referred to as the heart center, gives rhythm and purpose to our lives. As the feeling element, it gives vitality to our ideas and plans, and is the keeper of our ideals. Do you know your heart's desire? This article can help you explore the heart of your life path, and help you identify your...



An Atlas of Heart Rhythms
by Roy Pittman

Here are 90 pages of highly illustrative and legible EKG strips taken from actual clinical practice and presented in clear illustrations with concise explanatory text. Each strip is introduced with leading questions, then discussed in terms of the rhythm it illustrates and other interesting features it may have, moving from the very simple into greater depth and detail. This case-by-case...

Essentials of heart rhythm analysis
by Ira W Weiss



The Heart Rhythms (1921)
by Paul Dudley Lamson

Society defines competence for ICD implantation: Heart Rhythm Society defines criteria required to establish competence of nonelectrophysiologists.(Cardiovascular ... An article from: Internal Medicine News
by Joyce Frieden

This digital document is an article from Internal Medicine News, published by International Medical News Group on August 15, 2004. The length of the article is 752 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web...



Heart Rhythms
by Art Cornell

selected poems and photographs by art...

© 2008 BrightSurf.com